{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:04:28Z","timestamp":1778339068383,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Some 7-10% of patients on replacement renal therapy (RRT) are receiving it because of autosomal dominant polycystic kidney disease (ADPKD). The age at initiation of RRT is expected to increase over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Clinical data of 1,586 patients (7.9%) with ADPKD and 18,447 (92.1%) patients with other nephropathies were analysed from 1984 through 2009 (1984\u20131991, 1992\u20131999 and 2000\u20132009).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The age at initiation of RRT remained stable over the three periods in the ADPKD group (56.7\u2009\u00b1\u200910.9 (mean\u2009\u00b1\u2009SD) vs 57.5\u2009\u00b1\u200912.1 vs 57.8\u2009\u00b1\u200913.3 years), whereas it increased significantly in the non-ADPKD group (from 54.8\u2009\u00b1\u200916.8 to 63.9\u2009\u00b1\u200916.3 years, p\u2009&lt;\u20090.001). The ratio of males to females was higher for non-ADPKD than for ADPKD patients (1.6\u20131.8 vs 1.1\u20131.2). The prevalence of diabetes was significantly lower in the ADPKD group (6.76% vs 11.89%, p\u2009&lt;\u20090.001), as were most of the co-morbidities studied, with the exception of hypertension. The survival rate of the ADPKD patients on RRT was higher than that of the non-ADPKD patients (p\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Over time neither changes in age nor alterations in male to female ratio have occurred among ADPKD patients who have started RRT, probably because of the impact of unmodifiable genetic factors in the absence of a specific treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-14-186","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T10:14:41Z","timestamp":1378376081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry"],"prefix":"10.1186","volume":"14","author":[{"given":"V\u00edctor","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Comas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Arcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Manel","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salom\u00e9","family":"Muray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cabezuelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Ballar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Ars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"622_CR1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1681\/ASN.2009010014","volume":"20","author":"PC Harris","year":"2009","unstructured":"Harris PC: 2008 Homer W. Smith Award: insights into the pathogenesis of polycystic kidney disease from gene discovery. J Am Soc Nephrol. 2009, 20: 1188-1198. 10.1681\/ASN.2009010014.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1681\/ASN.V7102142","volume":"7","author":"R Torra","year":"1996","unstructured":"Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, et al: Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol. 1996, 7: 2142-2151.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer N, Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, et al: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999, 353: 103-107. 10.1016\/S0140-6736(98)03495-3.","journal-title":"Lancet"},{"key":"622_CR4","doi-asserted-by":"publisher","first-page":"A8, e1","DOI":"10.1053\/j.ajkd.2010.10.007","volume":"57","author":"AJ Collins","year":"2011","unstructured":"Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, et al: US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011, 57: A8, e1-A8,526.","journal-title":"Am J Kidney Dis"},{"key":"622_CR5","volume-title":"Generalitat de Catalunya","author":"Catalan Transplant Organisation HD","year":"2009","unstructured":"Catalan Transplant Organisation HD: Catalan Renal Registry. Generalitat de Catalunya. 2009, Barcelona: Generalitat de Catalunya, Servei Catala de la Salut, Statistical report. 20-11-2011. Ref Type: Catalog"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.ajkd.2005.05.029","volume":"46","author":"M Taylor","year":"2005","unstructured":"Taylor M, Johnson AM, Tison M, Fain P, Schrier RW: Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications. Am J Kidney Dis. 2005, 46: 415-423. 10.1053\/j.ajkd.2005.05.029.","journal-title":"Am J Kidney Dis"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/humu.22103","volume":"33","author":"MP Audrezet","year":"2012","unstructured":"Audrezet MP, Cornec-Le GE, Chen JM, Redon S, Quere I, Creff J, et al: Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat. 2012, 33: 1239-1250. 10.1002\/humu.22103.","journal-title":"Hum Mutat"},{"key":"622_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"GE Cornec-Le","year":"2013","unstructured":"Cornec-Le GE, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, et al: Type of PKD1 Mutation Influences Renal Outcome in ADPKD. J Am Soc Nephrol. 2013, 24: 1006-1013. 10.1681\/ASN.2012070650.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","volume":"17","author":"AB Chapman","year":"2010","unstructured":"Chapman AB, Stepniakowski K, Rahbari-Oskoui F: Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010, 17: 153-163. 10.1053\/j.ackd.2010.01.001.","journal-title":"Adv Chronic Kidney Dis"},{"key":"622_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10157-012-0611-9","volume":"16","author":"E Higashihara","year":"2012","unstructured":"Higashihara E, Horie S, Muto S, Mochizuki T, Nishio S, Nutahara K: Renal disease progression in autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2012, 16: 622-628. 10.1007\/s10157-012-0611-9.","journal-title":"Clin Exp Nephrol"},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","volume":"13","author":"JC Longenecker","year":"2002","unstructured":"Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002, 13: 1918-1927. 10.1097\/01.ASN.0000019641.41496.1E.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR12","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1097\/01.ASN.0000095249.99803.85","volume":"14","author":"MK Haroun","year":"2003","unstructured":"Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J: Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003, 14: 2934-2941. 10.1097\/01.ASN.0000095249.99803.85.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1523-1755.2002.00432.x","volume":"62","author":"SS Khan","year":"2002","unstructured":"Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT: Health care utilization among patients with chronic kidney disease. Kidney Int. 2002, 62: 229-236. 10.1046\/j.1523-1755.2002.00432.x.","journal-title":"Kidney Int"},{"key":"622_CR14","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1097\/HJH.0b013e32833e4fd8","volume":"28","author":"MZ Molnar","year":"2010","unstructured":"Molnar MZ, Lukowsky LR, Streja E, Dukkipati R, Jing J, Nissenson AR, et al: Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens. 2010, 28: 2475-2484.","journal-title":"J Hypertens"},{"key":"622_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.ajkd.2007.10.037","volume":"51","author":"BY Reed","year":"2008","unstructured":"Reed BY, McFann K, Reza BM, Nobkhthaghighi N, Masoumi A, Johnson AM, et al: Variation in age at ESRD in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2008, 51: 173-183. 10.1053\/j.ajkd.2007.10.037.","journal-title":"Am J Kidney Dis"},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2215\/CJN.01460210","volume":"5","author":"B Orskov","year":"2010","unstructured":"Orskov B, Romming S, Feldt-Rasmussen B, Strandgaard S, V: Improved Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease in Denmark. Clin J Am Soc Nephrol. 2010, 5: 2034-2039. 10.2215\/CJN.01460210.","journal-title":"Clin J Am Soc Nephrol"},{"key":"622_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1523-1755.2003.00776.x","volume":"63","author":"RW Schrier","year":"2003","unstructured":"Schrier RW, McFann KK, Johnson AM: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int. 2003, 63: 678-685. 10.1046\/j.1523-1755.2003.00776.x.","journal-title":"Kidney Int"},{"key":"622_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","volume":"57","author":"C Patch","year":"2011","unstructured":"Patch C, Charlton J, Roderick PJ, Gulliford MC: Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis. 2011, 57: 856-862. 10.1053\/j.ajkd.2011.01.023.","journal-title":"Am J Kidney Dis"},{"key":"622_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0272-6386(12)80179-X","volume":"24","author":"JH Stewart","year":"1994","unstructured":"Stewart JH: End-stage renal failure appears earlier in men than in women with polycystic kidney disease. Am J Kidney Dis. 1994, 24: 181-183.","journal-title":"Am J Kidney Dis"},{"key":"622_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1432-2277.2011.01237.x","volume":"24","author":"A Jacquet","year":"2011","unstructured":"Jacquet A, Pallet N, Kessler M, Hourmant M, Garrigue V, Rostaing L, et al: Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int. 2011, 24: 582-587. 10.1111\/j.1432-2277.2011.01237.x.","journal-title":"Transpl Int"},{"key":"622_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5414\/CNP60352","volume":"60","author":"KJ Jager","year":"2003","unstructured":"Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD: The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol. 2003, 60: 352-360. 10.5414\/CNP60352.","journal-title":"Clin Nephrol"},{"key":"622_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0272-6386(89)80068-X","volume":"14","author":"N Gretz","year":"1989","unstructured":"Gretz N, Zeier M, Geberth S, Strauch M, Ritz E: Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1989, 14: 178-183.","journal-title":"Am J Kidney Dis"},{"key":"622_CR23","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/ndt\/gfh317","volume":"19","author":"K Wakai","year":"2004","unstructured":"Wakai K, Nakai S, Kikuchi K, Iseki K, Miwa N, Masakane I, et al: Trends in incidence of end-stage renal disease in Japan, 1983\u20132000: age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant. 2004, 19: 2044-2052. 10.1093\/ndt\/gfh317.","journal-title":"Nephrol Dial Transplant"},{"key":"622_CR24","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","volume":"13","author":"R Schrier","year":"2002","unstructured":"Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, et al: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol. 2002, 13: 1733-1739. 10.1097\/01.ASN.0000018407.60002.B9.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5414\/CNP57208","volume":"57","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Agodoa LY: Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol. 2002, 57: 208-214. 10.5414\/CNP57208.","journal-title":"Clin Nephrol"},{"key":"622_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.ajkd.2011.01.019","volume":"57","author":"L Li","year":"2011","unstructured":"Li L, Szeto CC, Kwan BC, Chow KM, Leung CB, Kam-Tao LP: Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2011, 57: 903-907. 10.1053\/j.ajkd.2011.01.019.","journal-title":"Am J Kidney Dis"},{"key":"622_CR27","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, et al: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992, 41: 1311-1319. 10.1038\/ki.1992.195.","journal-title":"Kidney Int"},{"key":"622_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2215\/CJN.01581105","volume":"1","author":"E Dicks","year":"2006","unstructured":"Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS: Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol. 2006, 1: 710-717. 10.2215\/CJN.01581105.","journal-title":"Clin J Am Soc Nephrol"},{"key":"622_CR29","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","volume":"4","author":"J Yium","year":"1994","unstructured":"Yium J, Gabow P, Johnson A, Kimberling W, Martinez-Maldonado M: Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol. 1994, 4: 1670-1674.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000046231","volume":"21","author":"T Ecder","year":"2001","unstructured":"Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, et al: Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol. 2001, 21: 98-103. 10.1159\/000046231.","journal-title":"Am J Nephrol"},{"key":"622_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10157-012-0706-3","volume":"17","author":"A Ozkok","year":"2012","unstructured":"Ozkok A, Akpinar TS, Tufan F, Kanitez NA, Uysal M, Guzel M, et al: Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol. 2012, 17: 345-351.","journal-title":"Clin Exp Nephrol"},{"key":"622_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000341263","volume":"36","author":"I Helal","year":"2012","unstructured":"Helal I, Reed B, Schrier RW: Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment. Am J Nephrol. 2012, 36: 162-167. 10.1159\/000341263.","journal-title":"Am J Nephrol"},{"key":"622_CR33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2215\/CJN.03250410","volume":"6","author":"VE Torres","year":"2011","unstructured":"Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF, et al: Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011, 6: 640-647. 10.2215\/CJN.03250410.","journal-title":"Clin J Am Soc Nephrol"},{"key":"622_CR34","first-page":"490795","volume":"2011","author":"GM Virzi","year":"2010","unstructured":"Virzi GM, Corradi V, Panagiotou A, Gastaldon F, Cruz DN, de CM, et al: ADPKD: Prototype of Cardiorenal Syndrome Type 4. Int J Nephrol. 2010, 2011: 490795-","journal-title":"Int J Nephrol"},{"key":"622_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2369-3-7","volume":"3","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Agodoa LY: Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival. BMC Nephrol. 2002, 3: 7-10.1186\/1471-2369-3-7.","journal-title":"BMC Nephrol"},{"key":"622_CR36","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/ndt\/gfr747","volume":"27","author":"LR Lukowsky","year":"2012","unstructured":"Lukowsky LR, Molnar MZ, Zaritsky JJ, Sim JJ, Mucsi I, Kovesdy CP, et al: Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2012, 27: 2899-2907. 10.1093\/ndt\/gfr747.","journal-title":"Nephrol Dial Transplant"},{"key":"622_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2215\/CJN.04140510","volume":"6","author":"V Menon","year":"2010","unstructured":"Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M: Inflammation, Oxidative Stress, and Insulin Resistance in Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2010, 6: 7-13.","journal-title":"Clin J Am Soc Nephrol"},{"key":"622_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000424420","volume":"115","author":"R Torra","year":"1995","unstructured":"Torra R, Darnell A, Cleries M, Botey A, Revert L, Vela E: Polycystic kidney disease patients on renal replacement therapy: data from the Catalan Renal Registry. Contrib Nephrol. 1995, 115: 177-181.","journal-title":"Contrib Nephrol"},{"key":"622_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000343281","volume":"36","author":"I Helal","year":"2012","unstructured":"Helal I, Reed B, Mettler P, Mc FK, Tkachenko O, Yan XD, et al: Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol. 2012, 36: 362-370. 10.1159\/000343281.","journal-title":"Am J Nephrol"},{"key":"622_CR40","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/ki.1991.120","volume":"39","author":"A Herbelin","year":"1991","unstructured":"Herbelin A, Urena P, Nguyen AT, Zingraff J, scamps-Latscha B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991, 39: 954-960. 10.1038\/ki.1991.120.","journal-title":"Kidney Int"},{"key":"622_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ki.2011.411","volume":"81","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, et al: Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012, 81: 577-585. 10.1038\/ki.2011.411.","journal-title":"Kidney Int"},{"key":"622_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1081\/JDI-200056606","volume":"27","author":"O Johnston","year":"2005","unstructured":"Johnston O, O\u2019Kelly P, Donohue J, Walshe JJ, Little DM, Hickey D, et al: Favorable graft survival in renal transplant recipients with polycystic kidney disease. Ren Fail. 2005, 27: 309-314.","journal-title":"Ren Fail"},{"key":"622_CR43","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","volume":"27","author":"B Orskov","year":"2012","unstructured":"Orskov B, Sorensen VR, Feldt-Rasmussen B, Strandgaard S: Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant. 2012, 27: 1607-1613. 10.1093\/ndt\/gfr467.","journal-title":"Nephrol Dial Transplant"},{"key":"622_CR44","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","volume":"5","author":"GM Fick","year":"1995","unstructured":"Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995, 5: 2048-2056.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR45","first-page":"806","volume":"20","author":"E Rahman","year":"2009","unstructured":"Rahman E, Niaz FA, Al-Suwaida A, Nahrir S, Bashir M, Rahman H, et al: Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study. Saudi J Kidney Dis Transpl. 2009, 20: 806-810.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"622_CR46","doi-asserted-by":"publisher","first-page":"c42","DOI":"10.1159\/000334429","volume":"120","author":"R Haynes","year":"2012","unstructured":"Haynes R, Kheradmand F, Winearls CG: Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study. Nephron Clin Pract. 2012, 120: c42-c47. 10.1159\/000334429.","journal-title":"Nephron Clin Pract"},{"key":"622_CR47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/ki.1993.355","volume":"44","author":"JM Roscoe","year":"1993","unstructured":"Roscoe JM, Brissenden JE, Williams EA, Chery AL, Silverman M: Autosomal dominant polycystic kidney disease in Toronto. Kidney Int. 1993, 44: 1101-1108. 10.1038\/ki.1993.355.","journal-title":"Kidney Int"},{"key":"622_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.ackd.2009.12.006","volume":"17","author":"A Alam","year":"2010","unstructured":"Alam A, Perrone RD: Management of ESRD in patients with autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010, 17: 164-172. 10.1053\/j.ackd.2009.12.006.","journal-title":"Adv Chronic Kidney Dis"},{"key":"622_CR49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/ajkd.2002.32161","volume":"39","author":"C Fourtounas","year":"2002","unstructured":"Fourtounas C, Panteris V, Valis D: Survival after end-stage renal disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2002, 39: 660-","journal-title":"Am J Kidney Dis"},{"key":"622_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone RD, Ruthazer R, Terrin NC: Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001, 38: 777-784. 10.1053\/ajkd.2001.27720.","journal-title":"Am J Kidney Dis"},{"issue":"26","key":"622_CR51","first-page":"755","volume":"12","author":"PW Lee","year":"2012","unstructured":"Lee PW, Chien CC, Yang WC, Wang JJ, Lin CC: Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: a national study in Taiwan. J Nephrol. 2012, 12 (26): 755-762.","journal-title":"J Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-186\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:24:04Z","timestamp":1630545844000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-186","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]},"assertion":[{"value":"14 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"186"}}